Alcohol
Volume 32, Issue 3 , Pages 243-247 , April 2004

Serum cytokine concentrations in alcohol-dependent individuals without liver disease

  • Chryssoula Nicolaou

      Affiliations

    • Athens Medical School–Aeginition Hospital, Department of Biopathology, Vass Sophias av. 72-74, 115 28 Athens, Greece
    • ,
  • Stylianos Chatzipanagiotou

      Affiliations

    • Athens Medical School–Aeginition Hospital, Department of Biopathology, Vass Sophias av. 72-74, 115 28 Athens, Greece
    • ,
  • Dimitrios Tzivos

      Affiliations

    • Athens Medical School–Aeginition Hospital, Department of Biopathology, Vass Sophias av. 72-74, 115 28 Athens, Greece
    • ,
  • Elias Odusseas Tzavellas

      Affiliations

    • Athens Medical School–Aeginition Hospital, Department of Psychiatry, Vass. Sophias av. 72-74, 115 28 Athens, GreeceCorresponding Author Information
    • ,
  • Fotini Boufidou

      Affiliations

    • Athens Medical School–Aeginition Hospital, Department of Biopathology, Vass Sophias av. 72-74, 115 28 Athens, Greece
    • ,
  • Ioannis Alexandros Liappas

      Affiliations

    • Athens Medical School–Aeginition Hospital, Department of Psychiatry, Vass. Sophias av. 72-74, 115 28 Athens, GreeceCorresponding Author Information

Received 17 December 2003 ,Revised 25 February 2004 ,Accepted 28 February 2004.

References 

  1. American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders. 4th ed.. Washington, DC: Author; 1994;
  2. Bird GLA, Sheron N, Goka AKJ, Alexander GJ, William RS. Increased plasma tumor necrosis factor in severe alcoholic hepatitis. Ann Intern Med. 1990;112:917–920
  3. Bode C, Kugler V, Bode JC. Endotoxemia in patients with alcoholic and non-alcoholic cirrhosis and in subjects with no evidence of chronic liver disease following acute alcohol excess. J Hepatol. 1987;4:8–14
  4. Castilla A, Prieto J, Fausto N. Transforming growth factors beta 1 and alpha in chronic liver disease. Effects of interferon alfa therapy. N Engl J Med. 1991;324:933–940
  5. Daniluk J, Szuster-Ciesielska A, Drabko J, Kandefer-Szerszen M. Serum cytokine levels in alcohol-related liver cirrhosis. Alcohol. 2001;23:29–34
  6. Deviere J, Content J, Denys C, Vandenbussche P, Le Moine O, Schandene L, et al. Immunoglobulin A and interleukin-6 form a positive secretory feedback loop: a study of normal subjects and alcoholics cirrhotics. Gastroenterology. 1992;103:1296–1301
  7. Deviere J, Content J, Denys C, Vandenbussche P, Schandene L, Wybran J, et al. High interleukin-6 serum levels and increased production by leucocytes in alcoholic liver cirrhosis. Correlation with IgA serum levels and lymphokines production. Clin Exp Immunol. 1989;77:221–225
  8. Felver ME, Mezey E, McGuire M, Mitchell MC, Herlong HF, Veech GA, et al. Plasma tumor necrosis factor alpha predicts decreased long-term survival in severe alcoholic hepatitis. Alcohol Clin Exp Res. 1990;14:255–259
  9. Friedman H. Alcohol effects on cytokine responses by immunocytes. Alcohol Clin Exp Res. 1998;22(5 Suppl):184S–187S
  10. González-Quintela A, Dominguez-Santalla MJ, Pérez LF, Vidal C, Lojo S, Barrio E. Influence of acute alcohol intake and alcohol withdrawal on circulating levels of IL-6, IL-8, IL-10 and IL-12. Cytokine. 2000;12:1437–1440
  11. Hamilton M. The assessment of anxiety rates by rating. Br J Med Psychol. 1959;32:50–55
  12. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56–62
  13. Hill DB, Marsano L, Cohen D, Allen J, Shedlofsky S, McClain CJ. Increased plasma interleukin-6 concentrations in alcoholic hepatitis. J Lab Clin Med. 1992;119:547–552
  14. Hill DB, Marsano LS, McClain CJ. Increased plasma interleukin-8 concentrations in alcoholic hepatitis. Hepatology. 1993;18:576–580
  15. Huang YS, Chan CY, Wu JC, Pai CH, Chao Y, Lee SD. Serum levels of interleukin-8 in alcoholic liver disease: relationship with disease stage, biochemical parameters and survival. J Hepatol. 1996;24:377–384
  16. Hughes PH, Venulet J, Khant U, Medina Mora ME, Navartnam V, Poshyachinda V, et al. Core Data for Epidemiological Studies on Nonmedical Drug Use. Geneva: World Health Organization (WHO Offset Publication 56); 1980; pp. 1–100
  17. Joachim H. Klinbisch-chemischer Nachweis von chronischem Alkoholabusus. [The clinical chemical demonstration of chronic alcoholism.]. Dtsch Med Wochenschr. 1995;120:585
  18. Khoruts A, Stahnke L, McClain CJ, Logan G, Allen JI. Circulating tumor necrosis factor, interleukin-1 and interleukin-6 in chronic alcoholic patients. Hepatology. 1991;13:267–276
  19. Laso FJ, Iglesias MC, Lopez A, Ciudad J, San Miguel JF, Orfao A. Increased interleukin-12 serum levels in chronic alcoholism. J Hepatol. 1998;28:771–777
  20. Le Moine O, Marchant A, De Groote D, Azar C, Goldman M, Deviere J. Role of defective monocyte interleukin-10 release in tumor necrosis factor-alpha overproduction in alcoholics cirrhosis. Hepatology. 1995;22:1436–1439
  21. Magura S, Kang SY. Validity of self-reported drug use in high risk populations: a meta-analytical review. Subst Use Misuse. 1996;31:1131–1153
  22. McClain C, Hill D, Schmidt J, Diehl AM. Cytokines and alcoholic liver disease. Semin Liver Dis. 1993;13:170–182
  23. Sheron N, Bird G, Goka J, Alexander G, Williams R. Elevated plasma interleukin-6 and increased severity and mortality in alcoholic hepatitis. Clin Exp Immunol. 1991;84:449–453
  24. Sun Z, Klein AS, Radaeva S, Hong F, El-Assal O, Pan H-n, et al. In vitro interleukin-6 treatment prevents mortality associated with fatty liver transplants in rats. Gastroenterology. 2003;125:202–215
  25. World Health Organization. (1990). Composite International Diagnostic Interview. CIDI-Core Version 1.0, Division of Mental Health. Geneva: Author.

PII: S0741-8329(04)00053-9

doi: 10.1016/j.alcohol.2004.02.004

Alcohol
Volume 32, Issue 3 , Pages 243-247 , April 2004

Article Tools